[Cell therapy for Parkinson's disease: III. Neonatal, fetal and embryonic stem cell-based applications].

Motor dysfunctions in Parkinson's disease are believed to be primarily due to the degeneration of dopaminergic neurons located in the substantia nigra pars compacta. Numerous cell replacement therapy approaches have been developed and tested, including these based on donor cell transplantation (embryonic and adult tissue-derived), adult mesenchymal stem… CONTINUE READING